Maternal corticosteroid use and risk of selected congenital anomalies.
about
Safety of topical corticosteroids in pregnancySafety of topical corticosteroids in pregnancyPerinatal safety of topical corticosteroids for pregnant womenCongenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guidelinePregnancy and inflammatory bowel diseases: Current perspectives, risks and patient managementUse of inhaled and oral corticosteroids in pregnancy and the risk of malformations or miscarriageTreatment of pregnant women with a diagnosis of inflammatory bowel diseaseFindings on potential teratogens from a case-control study in Western AustraliaAnti-inflammatory and immunosuppressive drugs and reproductionPregnancy and Inflammatory Bowel DiseaseChallenges and treatment options for rheumatoid arthritis during pregnancy.Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing dataUpdate on new developments in the study of human teratogens.First-trimester nonsystemic corticosteroid use and the risk of oral clefts in Norway.Ocular changes during pregnancy.Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.Oral cleft prevention program (OCPP).Review article: acute severe ulcerative colitis - evidence-based consensus statements.Chemical exposure during pregnancy and oral clefts in newborns.Multiple sclerosis and pregnancy: maternal considerations.Corticosteroid use and risk of orofacial clefts.Corticosteroid use during pregnancy and risk of orofacial cleftsHeadache in pregnancy: an approach to emergency department evaluation and management.Fertility and pregnancy in the patient with inflammatory bowel disease.A comprehensive review of the genetic basis of cleft lip and palateUsing corticosteroids during pregnancy. Are topical, inhaled, or systemic agents associated with risk?Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation?A Spotty Liver of PregnancyMaternal food insecurity is associated with increased risk of certain birth defectsUse of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma.Maternal stressful life events and risks of birth defectsMeta-analysis finds use of inhaled corticosteroids during pregnancy safe: a systematic meta-analysis review.Treatment options for nausea and vomiting during pregnancy.Diagnosis and treatment of urticaria and angioedema: a worldwide perspective.The safety of pharmacological therapies for gastrointestinal conditions encountered during pregnancy.Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel diseaseEnvironmental factors related to the occurrence of oral clefts in a Brazilian subpopulation.Risk of miscarriage among users of corticosteroid hormones: a population-based nested case-control studyManagement of the pregnant IBD patient.Treatment of cluster headache in pregnancy and lactation.
P2860
Q24186366-17700C9B-B1BC-423F-924A-C0BA9BD97025Q24240069-913FC1A4-679E-441A-8D26-4293DE5E79C3Q24242500-F1720C0D-30DF-4211-B07C-57C79F5E6095Q24614223-FD3A1854-8336-4270-8CF3-411E31E5F3D1Q26777627-AE425A8E-FC4D-4F98-BB13-929A9D70B9A8Q26825323-EC8D8EDB-0F78-4599-BB9A-83746F170583Q28067821-A1BE8426-600B-4428-9AFB-6FDC8FA2D7B1Q28166703-086E94E0-4427-42ED-AC0A-AB113629B7D5Q28218219-3ED3B9FD-247A-47B7-A89C-E962EAD585EAQ28392552-4B3E5636-503E-4C04-9912-3EEAB887CB8EQ30249730-07177D58-3530-4FAA-BE42-FD9E5EBC88B3Q31044246-C6C6F2EB-F478-43E3-B2CE-DE4A6E68924CQ34123327-CA073CAF-5557-48E1-B5AF-CABBA963CEFAQ34169484-8D3D2024-F493-48B8-B57F-225844137ADFQ34192777-F9051B08-865F-4AC5-B487-65DBCD3A860EQ34244877-32B427D5-FD64-40F2-8730-C6AE1A018470Q34488750-04A3D9C1-0FE6-4B15-8C98-DC7B3AC073BCQ34528270-F5C1D185-7474-4431-AB07-6231D003426CQ34575090-5A045C9C-5BC2-4B52-AE42-8E37EBC38938Q34639869-BDF8109E-A783-4215-A926-8483F913F4B5Q34819115-0E209954-1BAF-4832-B76E-FE2101FD1580Q34828505-24438545-A969-495D-987F-05000500A925Q35235048-CEDCACAD-A466-4B55-8EA1-A5C0E01A1B9BQ35760599-AE3998B5-3224-47D4-AD74-8F5F59A1EB35Q35829617-195DD2BC-FF1F-471D-9B78-541A4CBC58FEQ35904649-A5E76671-04B4-473C-BE98-76081CA1F4F5Q35915182-0BD509EB-8D83-4602-9FA4-05322FAC62D1Q35927698-E8767D46-C971-49DF-A665-854460D851F9Q36116592-EC6B99DB-19C1-49FD-9873-DB72FF3175D1Q36166301-72C34507-3E0F-4680-90D5-771F5664B2F2Q36168830-598F970B-0457-43BA-AB12-8CFD8A374127Q36579868-FE19B990-26EF-4766-BC74-5F74C0060CBFQ36582675-F0FE97F6-B3AB-45DC-BC65-FCD03FD4C8FDQ36834774-02E1FEAA-C329-4100-8F39-87E139E94238Q36945003-BD78E9ED-0C76-4748-8492-830B82078903Q36989959-D35A2FCB-45D3-4F55-91FB-6B2E29201378Q37045635-DE98CE7F-4907-4E39-8547-52373748AA53Q37106222-FD56451F-0EBD-4EDC-99C5-CB43C2628AAFQ37216502-67A377D7-20D9-46FA-9295-72A8C7DAADD6Q37377970-FD2AC315-F43D-4740-919B-BA58A156E29B
P2860
Maternal corticosteroid use and risk of selected congenital anomalies.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Maternal corticosteroid use and risk of selected congenital anomalies.
@en
type
label
Maternal corticosteroid use and risk of selected congenital anomalies.
@en
prefLabel
Maternal corticosteroid use and risk of selected congenital anomalies.
@en
P2860
P1476
Maternal corticosteroid use and risk of selected congenital anomalies.
@en
P2093
Carmichael SL
P2860
P304
P356
10.1002/(SICI)1096-8628(19990917)86:3<242::AID-AJMG9>3.0.CO;2-U
P577
1999-09-01T00:00:00Z